Novel anti-platelet agents in acute coronary syndrome: mechanisms of action and opportunities to tailor therapy.

about

Novel anti-platelet agents in acute coronary syndrome: mechanisms of action and opportunities to tailor therapy.

Item

http://www.wikidata.org/entity/Q38366950

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

2015年學術文章

@zh

2015年學術文章

@zh-hant

name

Novel anti-platelet agents in ...... portunities to tailor therapy.

@en

type

Item

label

Novel anti-platelet agents in ...... portunities to tailor therapy.

@en

prefLabel

Novel anti-platelet agents in ...... portunities to tailor therapy.

@en

P1476

Novel anti-platelet agents in ...... pportunities to tailor therapy

@en

P2093

Daniel M Kolanksy

http://www.w3.org/2001/XMLSchema#string

Jay Giri

http://www.w3.org/2001/XMLSchema#string

Neha Quatromoni

http://www.w3.org/2001/XMLSchema#string

William H Matthai

http://www.w3.org/2001/XMLSchema#string

P2860

Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients

Consensus and update on the definition of on-treatment platelet reactivity to adenosine diphosphate associated with ischemia and bleeding

Response variability to P2Y12 receptor inhibitors: expectations and reality

Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study

Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation

Addition of clopidogrel to aspirin in 45,852 patients with acute myocardial infarction: randomised placebo-controlled trial

High post-treatment platelet reactivity identified low-responders to dual antiplatelet therapy at increased risk of recurrent cardiovascular events after stenting for acute coronary syndrome

Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial

Clopidogrel for coronary stenting: response variability, drug resistance, and the effect of pretreatment platelet reactivity

Heart disease and stroke statistics--2014 update: a report from the American Heart Association

P2888

s11883-015-0501-1

P304

501

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S11883-015-0501-1

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Sony Tuteja

P577

2015-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1013663175

http://www.w3.org/2001/XMLSchema#string

P698

25732742

http://www.w3.org/2001/XMLSchema#string